Wilmer Cutler Pickering Hale and Dorr is representing Verde Bioresins, Inc. in the transaction, and Snell & Wilmer is representing Nxu Inc. Verde Bioresins, Inc., a...
Nxu’s Merger with Verde Bioresins
MicroStrategy Incorporated’s $21 Billion At-the-Market Equity Offering
Wilmer Cutler Pickering Hale advised MicroStrategy Incorporated, and Davis Polk advised the Agents on the offering. MicroStrategy Incorporated (MicroStrategy) (Nasdaq: MSTR) announced the company’s new at-the-market...
State Street Corporation’s $2.3 Billion Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr represented State Street Corporation in the offering, and Cravath, Swaine & Moore represented the underwriters. State Street Corporation (“State Street”)...
Cresset’s Acquisition of CH Investment Partners
Wilmer Cutler Pickering Hale and Dorr represented CH Investment Partners in the transaction. Cresset Asset Management (“Cresset”) , an independent investment firm, announced its acquisition of...
McCormick’s $500 Million Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr represented McCormick & Company, Incorporated in the offering, and Weil, Gotshal & Manges represented the underwriters. McCormick & Company, Incorporated...
FTC v. U.S. Anesthesia Partners Inc and Welsh, Carson, Anderson & Stowe et al.
Ropes & Gray, Hogan Lovells, Yetter Coleman and Wilmer Cutler Pickering Hale and Dorr assisted Welsh, Carson, Anderson & Stowe in the case, while Kellogg, Hansen,...
Telix’s Acquisition of RLS
Wilmer Cutler Pickering Hale and Dorr represented Telix Pharmaceuticals Limited in the transaction. Telix Pharmaceuticals Limited (ASX: TLX) (Telix), a biopharmaceutical company, announced its acquisition of...
Nuvalent’s $575 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Nuvalent, Inc. in the offering, and Simpson Thacher & Bartlett represented the underwriters. Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage...
MicroStrategy Incorporated’s $1.01 Billion Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the several initial purchasers. MicroStrategy...
RunSafe’s $12 Million Series B Funding Round
Wilmer Cutler Pickering Hale and Dorr represented RunSafe Security in the transaction. RunSafe Security, the pioneer of a patented process to immunize software from cyberattacks without...
Viridian Therapeutics’ $258.8 Million Follow-on Public Offering
Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
Terns Pharmaceuticals’ $172.7 Million IPO
Wilmer Cutler Pickering Hale and Dorr and Cooley advised on Terns Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Terns Pharmaceuticals,...